Ono Pharmaceutical Co., Ltd. (OPHLY) has a market capitalization of $7.32B and trades at $5.19. The 52-week range is 3.28-5.75.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 0.1, Earnings Per Share (EPS) of $35.52, annual revenue of $486.87B.
The stock has a beta of 0.10, a last dividend of $0.1800, operates in the Healthcare sector.
